Drawing for RESTANA

USPTO serial 79049152

RESTANA

Reviewed by CopyMark Law Group

Reg. 3692659Status 404
Filing date
Status date
Registration date
Oct 6, 2009
Examiner
SOBRAL, CHRISTINA
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESTANA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005[Pharmaceutical preparations specially antidepressive, antipyretic, analgesic, anesthetics, antiallergic, antihistamine, antidote, detoxicates, antialcoholic, drugs against the smoked, namely, smoking cessation, inhalants, analeptics, hypocholesterolemic, antihemorrhoidal, capillary antifragilizadores, peripheric and cerebral vasodilators, corticosteroids, gastrointestinal, antiacid, antidiarrheal, antihelminthic, emetics and antiemetics, antiulcerous, antiflatulent, digestive antidyspeptic, laxatives, purgative, geriatrics, antifertility drugs and luteolytics, antiasthenics, energetics, antidiabetic, catabolics, antiobesity, anorexics, regulators of the metabolism, neurological central and peripherics system, parasympathomimetics, antiepileptic, medications against Parkinson diseases, hypnotic sedatives, neuroleptics, antiprolactinic, tranquilizing, antisicotic, tymoanaleptic, psychotonics, neurotropic, hormones, estrogenic, progestogenic, contraceptive, androgens, antihormones, antispasmodic, urogenital, antihypertensives, antiarrhyhthmics, anxiolytics, antipsychotics; pharmaceutical preparations for smoking cessation; pharmaceutical preparations for the treatment of insomnia, addiction, eating disorders, cognition, depression, and pain] *Pharmaceutical preparations for the neurological central system, pharmaceutical preparations for the treatment of insomnia.*SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 29, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 29, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
May 19, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 6, 2017INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 6, 2017INPCINVALIDATION PROCESSED—
Jan 13, 2017INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 13, 2016C71TCANCELLED SECTION 71—
Sep 29, 2013INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jun 24, 2013IRIVIRREGULARITY ON INVALIDATION RECEIVED FROM IB—
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 21, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 12, 2013INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 28, 2011INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 28, 2010A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Sep 28, 2010FAXXFAX RECEIVED—
Sep 8, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 7, 2010ES7RTEAS SECTION 7 REQUEST RECEIVED—
Feb 11, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 11, 2010FIMPFINAL DISPOSITION PROCESSED—
Jan 6, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 6, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 18, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 13, 2009OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 30, 2009OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 30, 2009OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 21, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2009NPUBNOTICE OF PUBLICATION—
Jun 15, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 12, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 11, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 27, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 14, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 10, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 10, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Oct 10, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 10, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 10, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2008ALIEASSIGNED TO LIE—
Sep 16, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2008RFNTREFUSAL PROCESSED BY IB—
Mar 19, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 19, 2008RFRRREFUSAL PROCESSED BY MPU—
Mar 19, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 18, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2008DOCKASSIGNED TO EXAMINER—
Feb 29, 2008NWAPNEW APPLICATION ENTERED—
Feb 28, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance